JESSICA FENNEWALD: Open Payments
NPI 1376856880 · CAMARILLO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,813 in 73 payments from 12 companies in 2025. Trend: 2023 $920 · 2024 $1,038 · 2025 $1,813
Food & beverage: $1,724Education: $89
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $493 |
| Janssen Biotech, Inc. | 8 | $492 |
| Phathom Pharmaceuticals, Inc. | 3 | $173 |
| Novo Nordisk Inc | 3 | $161 |
| Ardelyx, Inc. | 5 | $156 |
| PFIZER INC. | 4 | $88 |
| Gilead Sciences, Inc. | 3 | $72 |
| Regeneron Healthcare Solutions, Inc. | 3 | $62 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $43 |
| Ipsen Biopharmaceuticals, Inc | 1 | $27 |
Products named: TREMFYA, RINVOQ, VOQUEZNA, Wegovy, IBSRELA, DUPIXENT, XELJANZ, LINZESS.
Industry payments across CA — which companies pay providers there.
